{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:41:18Z","timestamp":1790732478869,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10792-012-9692-4","type":"journal-article","created":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T06:58:20Z","timestamp":1356937100000},"page":"571-577","source":"Crossref","is-referenced-by-count":24,"title":["Indocyanine green angiography-guided management of Vogt\u2013Koyanagi\u2013Harada disease: differentiation between choroidal scars and active lesions"],"prefix":"10.1007","volume":"33","author":[{"given":"Pascal B.","family":"Knecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl P.","family":"Herbort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,1]]},"reference":[{"key":"9692_CR1","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1167\/iovs.12-9863","volume":"53","author":"C Wang","year":"2012","unstructured":"Wang C, Tian Y, Lei B et al (2012) Decreased IL-27 expression in association with an increased Th17 response in Vogt\u2013Koyanagi\u2013Harada disease. Invest Ophthalmol Vis Sci 53:4668\u20134675","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9692_CR2","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1167\/iovs.11-8505","volume":"53","author":"Y Yang","year":"2012","unstructured":"Yang Y, Xiao X, Li F et al (2012) Increased IL-7 expression in Vogt\u2013Koyanagi\u2013Harada disease. Invest Ophthalmol Vis Sci 53:1012\u20131017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9692_CR3","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.4049\/jimmunol.165.12.7323","volume":"165","author":"K Yamaki","year":"2000","unstructured":"Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S (2000) Tyrosinase family proteins are antigens specific to Vogt\u2013Koyanagi\u2013Harada disease. J Immunol 165:7323\u20137329","journal-title":"J Immunol"},{"key":"9692_CR4","volume-title":"Uveitis","author":"R Nussenblatt","year":"2010","unstructured":"Nussenblatt R, Whitcup S (2010) Uveitis, 4th edn. Mosby Elsevier, Philadelphia","edition":"4"},{"key":"9692_CR5","volume-title":"Ophthalmology","author":"M Yanoff","year":"2009","unstructured":"Yanoff M, Duker JS (2009) Ophthalmology, 3rd edn. Mosby Elsevier, Philadelphia","edition":"3"},{"key":"9692_CR6","first-page":"241","volume":"6","author":"N Bouchenaki","year":"2011","unstructured":"Bouchenaki N, Herbort CP (2011) Indocyanine green angiography guided management of Vogt\u2013Koyanagi\u2013Harada disease. J Ophthalmic Vis Res 6:241\u2013248","journal-title":"J Ophthalmic Vis Res"},{"key":"9692_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10792-007-9060-y","volume":"27","author":"CP Herbort","year":"2007","unstructured":"Herbort CP, Mantovani A, Bouchenaki N (2007) Indocyanine green angiography in Vogt\u2013Koyanagi\u2013Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 27:173\u2013182","journal-title":"Int Ophthalmol"},{"issue":"Suppl","key":"9692_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/02713689008999417","volume":"9","author":"H Inomata","year":"1990","unstructured":"Inomata H, Sakamoto T (1990) Immunohistochemical studies of Vogt\u2013Koyanagi\u2013Harada disease with sunset sky fundus. Curr Eye Res 9(Suppl):35\u201340","journal-title":"Curr Eye Res"},{"key":"9692_CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10384-010-0853-6","volume":"54","author":"M Miyanaga","year":"2010","unstructured":"Miyanaga M, Kawaguchi T, Miyata K et al (2010) Indocyanine green angiography findings in initial acute pretreatment Vogt\u2013Koyanagi\u2013Harada disease in Japanese patients. Jpn J Ophthalmol 54:377\u2013382","journal-title":"Jpn J Ophthalmol"},{"key":"9692_CR10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bjo.82.10.1175","volume":"82","author":"AA Okada","year":"1998","unstructured":"Okada AA, Mizusawa T, Sakai J, Usui M (1998) Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt\u2013Koyanagi\u2013Harada syndrome. Br J Ophthalmol 82:1175\u20131181","journal-title":"Br J Ophthalmol"},{"key":"9692_CR11","first-page":"456","volume":"37","author":"M Yuzawa","year":"1993","unstructured":"Yuzawa M, Kawamura A, Matsui M (1993) Indocyanine green video-angiographic findings in Harada\u2019s disease. Jpn J Ophthalmol 37:456\u2013466","journal-title":"Jpn J Ophthalmol"},{"key":"9692_CR12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1167\/iovs.11-8984","volume":"53","author":"K Nakao","year":"2012","unstructured":"Nakao K, Abematsu N, Mizushima Y, Sakamoto T (2012) Optic disc swelling in Vogt\u2013Koyanagi\u2013Harada disease. Invest Ophthalmol Vis Sci 53:1917\u20131922","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9692_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0021-5155(99)00016-7","volume":"43","author":"S Suzuki","year":"1999","unstructured":"Suzuki S (1999) Quantitative evaluation of \u201csunset glow\u201d fundus in Vogt\u2013Koyanagi\u2013Harada disease. Jpn J Ophthalmol 43:327\u2013333","journal-title":"Jpn J Ophthalmol"},{"key":"9692_CR14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-9394(14)78239-X","volume":"47","author":"MJ Hogan","year":"1959","unstructured":"Hogan MJ, Kimura SJ, Thygeson P (1959) Signs and symptoms of uveitis I. Anterior uveitis. Am J Ophthalmol 47:155\u2013170","journal-title":"Am J Ophthalmol"},{"key":"9692_CR15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0161-6420(97)30359-5","volume":"104","author":"CP Herbort","year":"1997","unstructured":"Herbort CP, Guex-Crosier Y, de Ancos E, Pittet N (1997) Use of laser flare photometry to assess and monitor inflammation in uveitis. Ophthalmology 104:64\u201371; discussion 71\u201362","journal-title":"Ophthalmology"},{"issue":"8","key":"9692_CR16","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1111\/j.1755-3768.2012.02498.x","volume":"90","author":"AM Abu El-Asrar","year":"2012","unstructured":"Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM (2012) The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt\u2013Koyanagi\u2013Harada disease. Acta Ophthalmol 90(8):e603\u2013e608","journal-title":"Acta Ophthalmol"},{"key":"9692_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","volume":"142","author":"RW Read","year":"2006","unstructured":"Read RW, Yu F, Accorinti M et al (2006) Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt\u2013Koyanagi\u2013Harada disease. Am J Ophthalmol 142:119\u2013124","journal-title":"Am J Ophthalmol"},{"key":"9692_CR18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10792-008-9288-1","volume":"30","author":"T Kawaguchi","year":"2010","unstructured":"Kawaguchi T, Horie S, Bouchenaki N et al (2010) Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt\u2013Koyanagi\u2013Harada disease. Int Ophthalmol 30:41\u201350","journal-title":"Int Ophthalmol"},{"key":"9692_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0161-6420(00)00428-0","volume":"108","author":"N Bouchenaki","year":"2001","unstructured":"Bouchenaki N, Herbort CP (2001) The contribution of indocyanine green angiography to the appraisal and management of Vogt\u2013Koyanagi\u2013Harada disease. Ophthalmology 108:54\u201364","journal-title":"Ophthalmology"},{"key":"9692_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/RHU.0b013e3181ffdd4f","volume":"16","author":"SR Gupta","year":"2010","unstructured":"Gupta SR, Suhler EB, Rosenbaum JT (2010) Intravenous methylprednisolone can cause an acute, vision-threatening rise in intraocular pressure. J Clin Rheumatol 16:397\u2013398","journal-title":"J Clin Rheumatol"},{"key":"9692_CR21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/sarh.2002.50003","volume":"32","author":"H Badsha","year":"2003","unstructured":"Badsha H, Edwards CJ (2003) Intravenous pulses of methylprednisolone for systemic lupus erythematosus. Semin Arthritis Rheum 32:370\u2013377","journal-title":"Semin Arthritis Rheum"},{"key":"9692_CR22","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2003.011734","volume":"63","author":"G Haugeberg","year":"2004","unstructured":"Haugeberg G, Griffiths B, Sokoll KB, Emery P (2004) Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study. Ann Rheum Dis 63:940\u2013944","journal-title":"Ann Rheum Dis"},{"key":"9692_CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/106002808902301215","volume":"23","author":"BL Erstad","year":"1989","unstructured":"Erstad BL (1989) Severe cardiovascular adverse effects in association with acute, high-dose corticosteroid administration. DICP 23:1019\u20131023","journal-title":"DICP"},{"key":"9692_CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/09273940500227192","volume":"14","author":"NN Markomichelakis","year":"2006","unstructured":"Markomichelakis NN, Halkiadakis I, Papaeythymiou-Orchan S et al (2006) Intravenous pulse methylprednisolone therapy for acute treatment of serpiginous choroiditis. Ocul Immunol Inflamm 14:29\u201333","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"9692_CR25","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","volume":"97","author":"L Bartalena","year":"2012","unstructured":"Bartalena L, Krassas GE, Wiersinga W et al (2012) Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active graves\u2019 orbitopathy. J Clin Endocrinol Metab 97(12):4454\u20134463","journal-title":"J Clin Endocrinol Metab"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-012-9692-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-012-9692-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-012-9692-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T18:35:04Z","timestamp":1562524504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-012-9692-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9692"],"URL":"https:\/\/doi.org\/10.1007\/s10792-012-9692-4","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,1]]}}}